PRIME: Cognitive Outcome Following Major Burns
Launched by CHELSEA AND WESTMINSTER NHS FOUNDATION TRUST · Aug 7, 2017
Trial Information
Current as of June 26, 2025
Completed
Keywords
ClinConnect Summary
Patients were matched with for age, sex and IQ (as determined by National Adult Reading Test scores) controlled volunteers.
Participants were assessed for the following domains: verbal ability, verbal and visual learning, short-term memory, working memory, executive function, attention and processing speed. The domains were assessed with the following validated cognitive tests: The Hopkins Verbal Learning Test, Trail making parts A and B, phonemic, semantic and switching verbal fluency as well as the Cogstate computerised battery: Identification speed, Detection speed, One Card Learning ac...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Invasive ventilation on a Burns Intensive Care Unit (BICU) within the previous ten years
- • Burn injuries greater than 15% total body surface area (TBSA)
- • Adult
- Exclusion Criteria:
- • Admission to BICU for other illnesses that were not burn related (such as Toxic Epidermal Necrolysis Syndrome)
- • Evidence of head trauma
- • Known substance misuse or alcohol excess
- • Inability to understand plain verbal or written English
- • Severe mental health issues
- • Receiving formal psychiatric treatment
- • Currently held under the Mental Health Act
- • If the subject's psychological health was deemed to be at risk from inclusion
- • Imprisoned
- • Contraindications to MRI
- • non-compatible pacemakers
- • surgical metalwork or foreign bodies
- • severe claustrophobia
About Chelsea And Westminster Nhs Foundation Trust
Chelsea and Westminster NHS Foundation Trust is a leading healthcare organization in the UK, dedicated to delivering high-quality patient care and advancing medical research. With a focus on innovation and excellence, the Trust actively engages in clinical trials to evaluate new treatments and improve health outcomes. Its multidisciplinary team collaborates with various stakeholders to ensure rigorous study design, ethical conduct, and comprehensive patient safety. By fostering an environment of collaboration and research, Chelsea and Westminster NHS Foundation Trust aims to contribute significantly to the advancement of medical knowledge and the enhancement of healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Marcela P Vizcaychipi, MD PhD
Principal Investigator
Anaesthetic and Intensive Care Consultant
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials